QUYRIUX® INMUNOMOOD: Cancer treatment-induced immunosuppression and neutropenia

It accelerates the recovery of the immune system, reduces the vulnerability/fragility of the patient after the treatment cycle, preparing him/her to arrive in the best conditions for the next cycle where, once the treatment is finished, the levels of defense are restored to avoid opportunistic infections that can complicate the patient’s prognosis and even put his/her own life at risk.


Inter Cycles: Accelerates the recovery of the immune system. Reduces the vulnerability/fragility of the patient.

After Treatment: Restore defence levels. Avoid opportunistic infections.